Why has Nomi Health's COVID-19 testing volume decreased by 30% in the last month?

Introduction

The recent 30% decrease in Nomi Health's COVID-19 testing volume is a critical issue that demands immediate attention and a thorough analysis. As we delve into this problem, we'll employ a systematic approach to identify the root cause, validate our hypotheses, and develop both short-term and long-term solutions. Our goal is to not only address the current decline but also to strengthen our testing program for future resilience.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a seasonal factor at play. Has there been any change in COVID-19 case rates or public health guidelines in the last month?

Why it matters: Seasonal trends could explain the decrease and inform our strategy. Expected answer: Case rates have remained stable, but some restrictions have been lifted. Impact on approach: If confirmed, we'd need to focus on marketing and accessibility.

• Considering potential system issues, have there been any recent changes to our testing infrastructure or processes?

Why it matters: Technical problems could be causing artificial drops in reported numbers. Expected answer: No major changes, but a new reporting system was implemented. Impact on approach: If true, we'd prioritize technical audits and data validation.

• Thinking about user behavior, has there been any shift in demographics or testing patterns among our user base?

Why it matters: Changes in user composition could indicate market shifts or competitor actions. Expected answer: Some decrease in younger age groups, but overall demographics stable. Impact on approach: We'd focus on targeted outreach and user experience improvements.

• Regarding market dynamics, have any new competitors entered the space or existing ones changed their strategies?

Why it matters: Competitive pressures could be drawing users away from our service. Expected answer: One major pharmacy chain has expanded their testing services. Impact on approach: We'd need to reassess our value proposition and differentiators.